The US Food and Drug Administration (FDA) and the US Centres for Disease Control and Prevention (CDC) announced on Friday that they are determined to lift the pause regarding the use of the Johnson & Johnson COVID-19 vaccine, allowing its resumed use for adults.

The decision was made following a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunisation Practices (ACIP), said a joint statement. The pause was recommended on April 13 after reports of six cases of a rare and severe type of blood clot in individuals following administration of the Johnson & Johnson vaccine.